E-drug: Table of content Prescrire International, April 2000
-------------------------------------------------------------------------
Table of contents of Prescrire International, April 2000 - Volume 9 - Nr.
46
Prescrire International is the English language edition of La revue
Prescrire. It consists of a selection of articles of international interest
from the monthly French-language journal La revue Prescrire. Prescrire
International contains evaluations of new drugs and new indications,
information on adverse effects, and assessments of therapeutic
interventions.
(The April issue comes out with an index covering articles published
between 1995 and 1999)
EDITORIAL
Funding of medicines agencies
NEW PRODUCTS
1999 Prescrire Awards
Golden Pill not awarded
Abciximab (new indication)
Helpful in patients with unstable angina or undergoing percutaneous
coronary intervention
Paclitaxel and lung cancer (new preparation)
No better than cisplatin-based therapy
Gabapentin (new indication): Possibly helpful in partial epilepsy
Nabumetone (new preparation): Another NSAID with no proven innovation for
the patient
Efavirenz (new preparation): Offers an advantage as an alternative to HIV
protease inhibitors
News of Prescrire' reps monitoring network
ADVERSE EFFECTS
Pancytopenia due to the interaction of allopurinol with azathioprine or
mercaptopurine: Combinations should be avoided
Prohibition of phenolphthalein: Welcome withdrawal due to a poor
risk-benefit ratio
REVIEWS
Management of HIV-infected adults: Update on antiretroviral therapy
Tamoxifen unsuitable for primary prevention of breast cancer: No proven
benefit, clear risks
Don't exaggerate the systemic adverse effects of hepatitis B vaccination
Anecdotal reports of neurological conditions do not challenge benefits
Prescrire International is financed by subscription fees only. We cannot
provide free subscriptions. If you do not know the journal we can send you
a sample issue. Send us your name and address if you want to receive a
sample issue of Prescrire International. An annual subscription covers six
issues of Prescrire International plus an index to issues during the
previous five years and costs $ 60 (FF 310) for individuals, $38 (FF = 200)
for students, and 240$ (FF1240) for commercial institutions.
La revue Prescrire
Association Mieux Prescrire
BP 459
75527 Paris Cedex 11
France
Tel. 33 1 49 23 72 65
Fax 33 1 48 07 87 32
email : international@prescrire.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.